tiprankstipranks
BioArctic AB Class B (DE:B9A)
FRANKFURT:B9A
Holding DE:B9A?
Track your performance easily

BioArctic AB Class B (B9A) Stock Forecast & Price Target

13 Followers
See the Price Targets and Ratings of:

B9A Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
BioArctic
AB Class B
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

B9A Stock 12 Month Forecast

There Are No Analyst Ratings for DE:B9A In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

B9A Financial Forecast

B9A Earnings Forecast

Next quarter’s earnings estimate for B9A is -€0.06 with a range of -€0.07 to -€0.05. The previous quarter’s EPS was -€0.02. B9A beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 60.78% of the time in the same period. In the last calendar year B9A has Underperformed its overall industry.
Next quarter’s earnings estimate for B9A is -€0.06 with a range of -€0.07 to -€0.05. The previous quarter’s EPS was -€0.02. B9A beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 60.78% of the time in the same period. In the last calendar year B9A has Underperformed its overall industry.

B9A Sales Forecast

Next quarter’s sales forecast for B9A is €8.35M with a range of €7.78M to €9.16M. The previous quarter’s sales results were €6.62M. B9A beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 48.39% of the time in the same period. In the last calendar year B9A has Outperformed its overall industry.
Next quarter’s sales forecast for B9A is €8.35M with a range of €7.78M to €9.16M. The previous quarter’s sales results were €6.62M. B9A beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 48.39% of the time in the same period. In the last calendar year B9A has Outperformed its overall industry.

B9A Analyst Recommendation Trends

Rating
Apr 23
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
total
1
In the current month, B9A has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. B9A average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

B9A Stock Forecast FAQ

What is DE:B9A’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:B9A’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:B9A, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is BioArctic AB Class B a Buy, Sell or Hold?
      Currently, no data Available
      What is BioArctic AB Class B’s share price target?
      Currently, no data Available
      What do analysts say about BioArctic AB Class B?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of BioArctic AB Class B?
      To buy shares of DE:B9A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis